Literature DB >> 15377844

Clinicopathological significance of GADD45 gene alterations in human familial breast carcinoma.

Elisa Sensi1, Mariella Tancredi, Paolo Aretini, Giovanna Cipollini, Paola Collecchi, A Giuseppe Naccarato, Paolo Viacava, Generoso Bevilacqua, Maria A Caligo.   

Abstract

GADD45 is a DNA damage responsive gene, induced following BRCA1 expression. Mutations at GADD45 might substitute for p53 alterations in hereditary breast tumours characterized by wild-type p53. We analyzed GADD45 alterations in 59 (15 BRCA-associated) familial breast carcinomas. No mutations were found. LOH at GADD45 locus was identified in 19/59 tumours. GADD45 does not appear to be a frequent mutational target in hereditary breast cancer.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15377844     DOI: 10.1023/B:BREA.0000041625.60280.4a

Source DB:  PubMed          Journal:  Breast Cancer Res Treat        ISSN: 0167-6806            Impact factor:   4.872


  3 in total

Review 1.  Development and progression of colorectal neoplasia.

Authors:  Upender Manne; Chandrakumar Shanmugam; Venkat R Katkoori; Harvey L Bumpers; William E Grizzle
Journal:  Cancer Biomark       Date:  2010       Impact factor: 4.388

Review 2.  GADD45 proteins: central players in tumorigenesis.

Authors:  R E Tamura; J F de Vasconcellos; D Sarkar; T A Libermann; P B Fisher; L F Zerbini
Journal:  Curr Mol Med       Date:  2012-06       Impact factor: 2.222

3.  Analysis of GADD45A sequence variations in French Canadian families with high risk of breast cancer.

Authors:  Sylvie Desjardins; Geneviève Ouellette; Yvan Labrie; Jacques Simard; Francine Durocher
Journal:  J Hum Genet       Date:  2008-03-19       Impact factor: 3.172

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.